Outcomes of Multi-Drug Resistant Tuberculosis (MDR-TB) among a Cohort of South African Patients with High HIV Prevalence

• Jason E. Farley ,

  * E-mail: jfarley@son.jhmi.edu

  Affiliation Johns Hopkins University School of Nursing, Baltimore, Maryland, United States of America

  ⨯
• Malathi Ram,

  Affiliation Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• William Pan,

  Affiliation Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Stacie Waldman,

  Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America

  ⨯
• Gail H. Cassell,

  Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America

  ⨯
• Richard E. Chaisson,

  Affiliations Bloomberg School of Public Health, Baltimore, Maryland, United States of America, School of Medicine, Baltimore, Maryland, United States of America, Center for Tuberculosis Research, Baltimore, Maryland, United States of America

  ⨯
• Karin Weyer,

  Affiliation South African Medical Research Council, Tuberculosis Epidemiology and Intervention Research Unit, Pretoria, South Africa

  ⨯
• Joey Lancaster,

  Affiliation South African Medical Research Council, Tuberculosis Epidemiology and Intervention Research Unit, Pretoria, South Africa

  ⨯
• Martie Van der Walt

  Affiliation South African Medical Research Council, Tuberculosis Epidemiology and Intervention Research Unit, Pretoria, South Africa

  ⨯